tyre silk pharmaceutical raw china
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for tyre silk pharmaceutical raw china from 2024 to 2025. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2025, the company has completed 1 transactions, with a transaction quantity of 0 and a transaction weight of 300.
- Year Transactions Quantity Weight
- 2024 0 0 0
- 2025 1 0 300
Bill of lading data
< 1/1 >- Trade date 2025/06/17 B/L No. ——
- Suppliers tyre silk pharmaceutical raw china Buyers orion pharma limited change from
- POLs —— PODs dhaka
- Supply area China Purchas area Bangladesh
- Weight 300kg Amount 24900
- Hs code 29214900 Product tags raw material,alverine citrate
- Product description PH: RAW MATERIAL: ALVERINE CITRATE Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 orion pharma limited change from bangladeshbuyer,they trade on 2025-06-17 1 100.00% >
Products
Total 2- Products Transactions Per Detail
-
alverine citrate
1 100% > -
raw material
1 100% >
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 29214900 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- bangladesh 1 100.00% >